This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

I. Clinical Results in Rheumatoid Arthritis and Laboratory Studies

J. B. R. McKENDRY, M.D.; C. A. SCHAFFENBURG, M.D.; E. PERRY McCULLAGH, M.D.

AMA Arch Intern Med. 1951;87(2):190-198.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THE EFFECTS of therapy with pituitary adrenocorticotropic hormone (ACTH) and cortisone in rheumatoid arthritis have stimulated clinical trials of more readily available steroids and related compounds. Of this group, desoxycorticosterone acetate combined with ascorbic acid has been introduced relatively recently and because of its availability has already been tried in many centers throughout the world.

The first report of the use of combined desoxycorticosterone acetate and ascorbic acid was the preliminary communication of Lewin and Wassén¹ in The Lancet of Nov. 26, 1949. The Swedish workers treated six women and three men with rheumatoid arthritis by administering 5 mg. of desoxycorticosterone acetate intramuscularly, followed within five minutes by the giving of 1,000 mg. of ascorbic acid intravenously. In all nine of their patients prompt improvement was reported, with almost complete subsidence of pain and definite increase in joint motility within 15 to 30 minutes. Improvement persisted from two to . . . [Full Text PDF of this Article]

Author Affiliations
CLEVELAND

From the Cleveland Clinic and the Frank E. Bunts Educational Institute.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?